PHOENIX Pharma and Voigt’s Joint Venture for Constitution of Avosano AG

Homburger advises PHOENIX Pharma Switzerland on the transaction.After receiving clearance from the Swiss Competition Commission, PHOENIX Pharma Switzerland and the Voigt Group completed the transaction to…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Marco Zingaro

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here